The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly

  title={The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly},
  author={Laura de Marinis and Antonio Bianchi and Gherardo Mazziotti and Marco Mettimano and Domenico Milardi and Alessandra Fusco and Vincenzo Cimino and G Maira and Alfredo Pontecorvi and Andrea Giustina},
The aim of this longitudinal study was to evaluate the echocardiographic outcome of acromegalic heart disease in patients undergoing different therapeutic approaches, in order to investigate whether SSA could provide therapeutic advantages as compared with neurosurgery. In total of 36, consecutive patients undergoing SSA treatment after neurosurgery were enrolled in this study (Gr.Surg.-SSA). After 12 months of treatment, 21 patients had a controlled disease, while the remaining 15 patients… CONTINUE READING
13 Citations
48 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 13 extracted citations


Publications referenced by this paper.
Showing 1-10 of 48 references

Differential expression of somatostatin receptor subtypes 1–5 proteins in numerous normal human tissues

  • N Unger, H Tourné, S Schulz
  • Abs 192 European Congress of Endocrinology
  • 2005

Similar Papers

Loading similar papers…